AltaValve System Shows Promise for Severe Mitral Regurgitation in 1-Year Results

(MedPage Today) -- The AltaValve transcatheter mitral valve replacement (TMVR) system had sustained effects among patients with severe mitral regurgitation out to 1 year, according to an early feasibility study (EFS). Among 30 participants with...
Source
MedPage Today
Opens original article in a new tab



